Mount Sinai Health System

The Tisch Cancer Institute Seminar Series

Presenter: J. Silvio Gutkind, PhD

Title: “Targeting the mTOR and Hippo Signaling Network in Cancer: Opportunities for Multimodal Precision Immunotherapies”

Please join the meeting 10 minutes before start time to facilitate access.

Join Zoom Meeting (web link is preferred for use)
https://mssm.zoom.us/s/92638961334

Join by phone:

19294362866 ,92638961334, 13017158592, 92638961334#

Meeting ID: 926 3896 1334

 

 

Dial-In Information

Join Zoom Meeting (web link is preferred for use)

https://mssm.zoom.us/s/92638961334

Meeting ID: 926 3896 1334

 

Tuesday, September 22 at 12:00pm to 1:00pm

Virtual Event
Event Type

Academic, Lecture/Seminar

Audience

Alumni, Faculty, Postdocs, Students, Prospective Students, Prospective Faculty

Campus

Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital

Education

Medical Education, Graduate Education, Postdoctoral Affairs, Fellowships

Departments

Oncological Sciences

Institutes

The Tisch Cancer Institute

Group
Biophysics and Systems Pharmacology (BSP), Cancer Biology (CAB), Developmental and Stem Cell Biology (DSCB), Genetics and Genomic Sciences (GGS), Immunology (IMM)
Presenter(s)

J. Silvio Gutkind, PhD
Distinguished Professor of Pharmacology
Associate Director of Basic Science
Member, National Academy of Medicine
UC San Diego Moores Cancer Center

Subscribe